Published in J Cell Biol on August 08, 2011
The cell biology of disease: cellular and molecular mechanisms underlying muscular dystrophy. J Cell Biol (2013) 1.45
Hypertrophic and dilated cardiomyopathy: four decades of basic research on muscle lead to potential therapeutic approaches to these devastating genetic diseases. Biophys J (2014) 1.44
Molecular consequences of the R453C hypertrophic cardiomyopathy mutation on human β-cardiac myosin motor function. Proc Natl Acad Sci U S A (2013) 1.42
Small molecule-induced cytosolic activation of protein kinase Akt rescues ischemia-elicited neuronal death. Proc Natl Acad Sci U S A (2012) 1.32
Abnormal muscle mechanosignaling triggers cardiomyopathy in mice with Marfan syndrome. J Clin Invest (2014) 1.13
The myosin mesa and a possible unifying hypothesis for the molecular basis of human hypertrophic cardiomyopathy. Biochem Soc Trans (2015) 1.01
Cellular mechanosensing: getting to the nucleus of it all. Prog Biophys Mol Biol (2014) 0.99
CTIP2 is a negative regulator of P-TEFb. Proc Natl Acad Sci U S A (2013) 0.99
Small heat shock proteins in redox metabolism: implications for cardiovascular diseases. Int J Biochem Cell Biol (2012) 0.99
Effects of troponin T cardiomyopathy mutations on the calcium sensitivity of the regulated thin filament and the actomyosin cross-bridge kinetics of human β-cardiac myosin. PLoS One (2013) 0.92
To divide or not to divide: revisiting liver regeneration. Cell Div (2013) 0.91
Ensemble force changes that result from human cardiac myosin mutations and a small-molecule effector. Cell Rep (2015) 0.90
Altered myocardial calcium cycling and energetics in heart failure-a rational approach for disease treatment. Cell Metab (2015) 0.89
hnRNP U protein is required for normal pre-mRNA splicing and postnatal heart development and function. Proc Natl Acad Sci U S A (2015) 0.89
Contractility parameters of human β-cardiac myosin with the hypertrophic cardiomyopathy mutation R403Q show loss of motor function. Sci Adv (2015) 0.85
Mutations in LMNA modulate the lamin A--Nesprin-2 interaction and cause LINC complex alterations. PLoS One (2013) 0.84
Identification and characterization of a novel genetic mutation with prolonged QT syndrome in an unexplained postoperative death. Int J Legal Med (2013) 0.84
Cell death and serum markers of collagen metabolism during cardiac remodeling in Cavia porcellus experimentally infected with Trypanosoma cruzi. PLoS Negl Trop Dis (2013) 0.83
Cardiotrophin 1 stimulates beneficial myogenic and vascular remodeling of the heart. Cell Res (2017) 0.82
Investigation of Pathogenic Genes in Chinese sporadic Hypertrophic Cardiomyopathy Patients by Whole Exome Sequencing. Sci Rep (2015) 0.82
Estrogen-related receptor α (ERRα) and ERRγ are essential coordinators of cardiac metabolism and function. Mol Cell Biol (2015) 0.81
Functions of autophagy in pathological cardiac hypertrophy. Int J Biol Sci (2015) 0.81
Protective effect of survivin in Doxorubicin-induced cell death in h9c2 cardiac myocytes. Korean Circ J (2013) 0.81
Mechanistic heterogeneity in contractile properties of α-tropomyosin (TPM1) mutants associated with inherited cardiomyopathies. J Biol Chem (2014) 0.81
Titration of mitochondrial fusion rescues Mff-deficient cardiomyopathy. J Cell Biol (2015) 0.81
The Mechanobiology of Aging. Annu Rev Biomed Eng (2015) 0.81
Gene expression patterns in transgenic mouse models of hypertrophic cardiomyopathy caused by mutations in myosin regulatory light chain. Arch Biochem Biophys (2016) 0.80
Cardiomyocyte-enriched protein CIP protects against pathophysiological stresses and regulates cardiac homeostasis. J Clin Invest (2015) 0.80
Proteomic analysis of physiological versus pathological cardiac remodeling in animal models expressing mutations in myosin essential light chains. J Muscle Res Cell Motil (2015) 0.80
Rescue of neonatal cardiac dysfunction in mice by administration of cardiac progenitor cells in utero. Nat Commun (2015) 0.79
Retracted Bmi1 limits dilated cardiomyopathy and heart failure by inhibiting cardiac senescence. Nat Commun (2015) 0.79
Poorly understood aspects of striated muscle contraction. Biomed Res Int (2015) 0.78
Heading in the Right Direction: Understanding Cellular Orientation Responses to Complex Biophysical Environments. Cell Mol Bioeng (2015) 0.78
Fibrous scaffolds for building hearts and heart parts. Adv Drug Deliv Rev (2015) 0.78
The L-type Ca2+ channels blocker nifedipine represses mesodermal fate determination in murine embryonic stem cells. PLoS One (2013) 0.77
Mutation of the calmodulin binding motif IQ of the L-type Ca(v)1.2 Ca2+ channel to EQ induces dilated cardiomyopathy and death. J Biol Chem (2012) 0.77
Hypothesis and theory: mechanical instabilities and non-uniformities in hereditary sarcomere myopathies. Front Physiol (2014) 0.77
Small molecules for cell reprogramming and heart repair: progress and perspective. ACS Chem Biol (2014) 0.77
Cardiac Gab1 deletion leads to dilated cardiomyopathy associated with mitochondrial damage and cardiomyocyte apoptosis. Cell Death Differ (2015) 0.77
Oestrogen enhances cardiotoxicity induced by Sunitinib by regulation of drug transport and metabolism. Cardiovasc Res (2015) 0.77
A small molecule inhibitor of mutant IDH2 rescues cardiomyopathy in a D-2-hydroxyglutaric aciduria type II mouse model. J Inherit Metab Dis (2016) 0.76
Cardiac inflammation in genetic dilated cardiomyopathy caused by MYBPC3 mutation. J Mol Cell Cardiol (2016) 0.75
A Novel HRAS Mutation Independently Contributes to Left Ventricular Hypertrophy in a Family with a Known MYH7 Mutation. PLoS One (2016) 0.75
Cathepsins in heart disease-chewing on the heartache? Am J Physiol Heart Circ Physiol (2015) 0.75
Molecular Characterization of Pediatric Restrictive Cardiomyopathy from Integrative Genomics. Sci Rep (2017) 0.75
Biology of the cardiac myocyte in heart disease. Mol Biol Cell (2016) 0.75
Real-time monitoring of hypertrophy in HL-1 cardiomyocytes by impedance measurements reveals different modes of growth. Cytotechnology (2016) 0.75
Abnormalities in Alternative Splicing of Apoptotic Genes and Cardiovascular Diseases. Int J Mol Sci (2015) 0.75
miR-218 Involvement in Cardiomyocyte Hypertrophy Is Likely through Targeting REST. Int J Mol Sci (2016) 0.75
A human MYBPC3 mutation appearing about 10 centuries ago results in a hypertrophic cardiomyopathy with delayed onset, moderate evolution but with a risk of sudden death. BMC Med Genet (2012) 0.75
Pharmacological Modulation of Calcium Homeostasis in Familial Dilated Cardiomyopathy: An In Vitro Analysis From an RBM20 Patient-Derived iPSC Model. Clin Transl Sci (2016) 0.75
Talin Is Required Continuously for Cardiomyocyte Remodeling during Heart Growth in Drosophila. PLoS One (2015) 0.75
Hypertrophic Cardiomyopathy Cardiac Troponin C Mutations Differentially Affect Slow Skeletal and Cardiac Muscle Regulation. Front Physiol (2017) 0.75
Administration of granulocyte-colony stimulating factor accompanied with a balanced diet improves cardiac function alterations induced by high fat diet in mice. BMC Cardiovasc Disord (2015) 0.75
Elucidation of MRAS-mediated Noonan syndrome with cardiac hypertrophy. JCI Insight (2017) 0.75
Delineation of Molecular Pathways Involved in Cardiomyopathies Caused by Troponin T Mutations. Mol Cell Proteomics (2016) 0.75
A simple model of pumping function of the left ventricle of the heart. Dokl Biochem Biophys (2015) 0.75
Co-Inflammatory Roles of TGFβ1 in the Presence of TNFα Drive a Pro-inflammatory Fate in Mesenchymal Stem Cells. Front Immunol (2017) 0.75
ALPK3 gene mutation in a patient with congenital cardiomyopathy and dysmorphic features. Cold Spring Harb Mol Case Stud (2017) 0.75
Proteomic analysis of endothelin-1 targets in the regulation of cardiomyocyte proliferation. Curr Top Med Chem (2016) 0.75
Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med (2001) 18.91
A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell (1998) 13.56
The failing heart--an engine out of fuel. N Engl J Med (2007) 12.06
Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med (2004) 11.40
Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol (2006) 10.71
Isolated noncompaction of left ventricular myocardium. A study of eight cases. Circulation (1990) 7.87
Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol (2003) 6.99
Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation (1995) 6.55
Apoptosis in the failing human heart. N Engl J Med (1997) 6.35
Apoptosis in myocytes in end-stage heart failure. N Engl J Med (1996) 6.19
Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest (2005) 5.48
The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell (2001) 5.35
Isolated noncompaction of the myocardium in adults. Mayo Clin Proc (1997) 4.63
Arrhythmogenic right ventricular cardiomyopathy. Lancet (2009) 4.46
Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med (2000) 4.30
Noncompaction of the ventricular myocardium. Circulation (2004) 4.19
Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol (2001) 4.17
Transgenic Galphaq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci U S A (1997) 3.89
Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res (2004) 3.72
Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol (1997) 3.64
The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med (1992) 3.53
Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J Biol Chem (2002) 3.22
Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ Res (2000) 3.08
Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Res (2006) 2.95
Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation (1998) 2.91
Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation (1996) 2.87
Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy. Cell (1999) 2.68
Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β. J Clin Invest (2010) 2.64
Decompensation of pressure-overload hypertrophy in G alpha q-overexpressing mice. Circulation (1998) 2.62
Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy. Lancet (2000) 2.57
Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy. Proc Natl Acad Sci U S A (2000) 2.47
Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. EMBO J (1993) 2.44
Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci U S A (1999) 2.42
Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy. J Cell Biol (2000) 2.40
Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest (1997) 2.29
Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines. Circ Res (1982) 2.26
Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res (1997) 2.25
Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest (1996) 2.21
The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. Circulation (2006) 2.13
Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation (1996) 2.10
Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol (2002) 2.07
Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations. J Clin Invest (2003) 2.04
The morphological spectrum of ventricular noncompaction. Cardiol Young (2005) 1.96
Small amounts of alpha-myosin heavy chain isoform expression significantly increase power output of rat cardiac myocyte fragments. Circ Res (2002) 1.91
NRSF regulates the fetal cardiac gene program and maintains normal cardiac structure and function. EMBO J (2003) 1.87
Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium. Circulation (2006) 1.84
Losing heart: the role of apoptosis in heart disease--a novel therapeutic target? FASEB J (2002) 1.81
Isolated noncompaction of the left ventricular myocardium in the adult is an autosomal dominant disorder in the majority of patients. Am J Med Genet A (2003) 1.80
Myosin isoenzymic distribution correlates with speed of myocardial contraction. J Mol Cell Cardiol (1981) 1.79
Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group. J Am Coll Cardiol (1999) 1.71
The alpha 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy. J Biol Chem (1993) 1.68
Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography. Am J Cardiol (1984) 1.67
Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. Circ Res (1988) 1.58
Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy. Mol Med (1996) 1.54
Cardiac myocyte-specific HIF-1alpha deletion alters vascularization, energy availability, calcium flux, and contractility in the normoxic heart. FASEB J (2004) 1.53
Diastolic dysfunction and its histopathological correlation in obstructive hypertrophic cardiomyopathy in children and adolescents. J Am Soc Echocardiogr (2009) 1.50
Sudden unexpected nontraumatic death in 54 young adults: a 30-year population-based study. Am J Cardiol (1995) 1.48
Cardiac overexpression of a G(q) inhibitor blocks induction of extracellular signal-regulated kinase and c-Jun NH(2)-terminal kinase activity in in vivo pressure overload. Circulation (2001) 1.46
Akt1 in the cardiovascular system: friend or foe? J Clin Invest (2005) 1.43
Kinetic differences at the single molecule level account for the functional diversity of rabbit cardiac myosin isoforms. J Physiol (1999) 1.43
Familial dilated cardiomyopathy in the United Kingdom. Br Heart J (1995) 1.37
X-linked dilated cardiomyopathy. N Engl J Med (1987) 1.36
Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching. Endocrinology (1993) 1.35
Glycogen synthase kinase-3beta regulates growth, calcium homeostasis, and diastolic function in the heart. J Biol Chem (2004) 1.33
Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy. J Am Coll Cardiol (1995) 1.32
Glycolysis is predominant source of myocardial ATP production immediately after birth. Am J Physiol (1991) 1.32
Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy. Neuromuscul Disord (1999) 1.32
Primary restrictive cardiomyopathy: clinical and pathologic characteristics. J Am Coll Cardiol (1991) 1.30
alpha- and beta-adrenergic pathways differentially regulate cell type-specific apoptosis in rat cardiac myocytes. Circulation (1999) 1.30
Prostaglandin F2 alpha stimulates hypertrophic growth of cultured neonatal rat ventricular myocytes. J Biol Chem (1996) 1.29
Thin filament disinhibition by restrictive cardiomyopathy mutant R193H troponin I induces Ca2+-independent mechanical tone and acute myocyte remodeling. Circ Res (2007) 1.29
Soy diet worsens heart disease in mice. J Clin Invest (2006) 1.29
Extracellular signal-regulated protein kinase activation is required for the anti-hypertrophic effect of atrial natriuretic factor in neonatal rat ventricular myocytes. J Biol Chem (1999) 1.28
Apoptosis of cardiac myocytes in Gsalpha transgenic mice. Circ Res (1999) 1.28
COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes. J Mol Biol (1999) 1.21
Bioinformatics assessment of beta-myosin mutations reveals myosin's high sensitivity to mutations. Trends Cardiovasc Med (2008) 1.20
Calcium-independent negative inotropy by beta-myosin heavy chain gene transfer in cardiac myocytes. Circ Res (2007) 1.16
Stretch-activated and background non-selective cation channels in rat atrial myocytes. J Physiol (2000) 1.13
Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use. Am J Clin Pathol (2008) 1.12
Cardiomyocyte preparation, culture, and gene transfer. Methods Mol Biol (2007) 1.08
Progression from hypertrophic cardiomyopathy to dilated cardiomyopathy. J Natl Med Assoc (1989) 1.08
Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy. Ann Intern Med (2010) 1.07
A new method of attachment of isolated mammalian ventricular myocytes for tension recording: length dependence of passive and active tension. J Mol Cell Cardiol (1990) 1.07
Left ventricular non-compaction: clinical features and cardiovascular magnetic resonance imaging. BMC Cardiovasc Disord (2009) 1.07
A polymorphic modifier gene alters the hypertrophic response in a murine model of familial hypertrophic cardiomyopathy. J Mol Cell Cardiol (2001) 1.06
Early changes in excitation-contraction coupling: transition from compensated hypertrophy to failure in Dahl salt-sensitive rat myocytes. Cardiovasc Res (1998) 1.03
Infantile restrictive cardiomyopathy resulting from a mutation in the cardiac troponin T gene. Pediatrics (2006) 0.98
Diabetic cardiomyopathy: signaling defects and therapeutic approaches. Expert Rev Cardiovasc Ther (2010) 0.97
Peripartum cardiomyopathy. Cardiol Rev (2005) 0.96
Atrial pressure and secretion of atrial natriuretic factor into the human central circulation. J Am Coll Cardiol (1986) 0.95
Two-photon laser scanning microscopy of the transverse-axial tubule system in ventricular cardiomyocytes from failing and non-failing human hearts. Cardiol Res Pract (2010) 0.95
Energetics and function of the failing human heart with dilated or hypertrophic cardiomyopathy. Eur J Clin Invest (1999) 0.94
Apoptotic myocardial cell death in the setting of arrhythmogenic right ventricular cardiomyopathy. Acta Cardiol (2005) 0.93
Cardiac troponin mutations and restrictive cardiomyopathy. J Biomed Biotechnol (2010) 0.93
A de novo mutation of the beta cardiac myosin heavy chain gene in an infantile restrictive cardiomyopathy. Congenit Heart Dis (2008) 0.93
Angiotensin II type 2 receptors and cardiac hypertrophy in women with hypertrophic cardiomyopathy. Hypertension (2001) 0.90
The role of Akt/GSK-3beta signaling in familial hypertrophic cardiomyopathy. J Mol Cell Cardiol (2009) 0.90
Alcoholic cardiomyopathy. J Cardiovasc Med (Hagerstown) (2010) 0.89
Signaling pathways mediating the response to hypertrophic stress in the heart. Gene Expr (1999) 0.88
Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation (2006) 4.69
Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease. Circ Res (2004) 2.45
A PGC-1α isoform induced by resistance training regulates skeletal muscle hypertrophy. Cell (2012) 2.35
The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity. Nature (2012) 2.33
Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav Immun (2009) 2.19
Genetic variability in forced and voluntary endurance exercise performance in seven inbred mouse strains. J Appl Physiol (1985) (2002) 2.15
Exercise can prevent and reverse the severity of hypertrophic cardiomyopathy. Circ Res (2006) 2.09
Gene mutations and genomic rearrangements in the mouse as a result of transposon mobilization from chromosomal concatemers. PLoS Genet (2006) 1.84
Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med (2002) 1.76
Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10. Eur J Neurosci (2005) 1.73
Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats. Brain Behav Immun (2006) 1.67
Controlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10. Mol Pain (2005) 1.66
Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain. Pain (2006) 1.66
Hibernating squirrel muscle activates the endurance exercise pathway despite prolonged immobilization. Exp Neurol (2013) 1.52
Crosslinked hyaluronan scaffolds as a biologically active carrier for valvular interstitial cells. Biomaterials (2005) 1.51
Competencies: a cure for pre-med curriculum. Science (2011) 1.47
Designing scaffolds for valvular interstitial cells: cell adhesion and function on naturally derived materials. J Biomed Mater Res A (2004) 1.43
Uncoupling of expression of an intronic microRNA and its myosin host gene by exon skipping. Mol Cell Biol (2010) 1.43
Molecular consequences of the R453C hypertrophic cardiomyopathy mutation on human β-cardiac myosin motor function. Proc Natl Acad Sci U S A (2013) 1.42
Redirecting valvular myofibroblasts into dormant fibroblasts through light-mediated reduction in substrate modulus. PLoS One (2012) 1.41
Fatty acids identified in the Burmese python promote beneficial cardiac growth. Science (2011) 1.30
Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner. Cancer Res (2010) 1.30
Soy diet worsens heart disease in mice. J Clin Invest (2006) 1.29
Loaded wheel running and muscle adaptation in the mouse. Am J Physiol Heart Circ Physiol (2005) 1.23
Hydrogels preserve native phenotypes of valvular fibroblasts through an elasticity-regulated PI3K/AKT pathway. Proc Natl Acad Sci U S A (2013) 1.20
Bioinformatics assessment of beta-myosin mutations reveals myosin's high sensitivity to mutations. Trends Cardiovasc Med (2008) 1.20
Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension. J Mol Cell Cardiol (2011) 1.19
Sex modifies exercise and cardiac adaptation in mice. Am J Physiol Heart Circ Physiol (2004) 1.18
Functional diversity among a family of human skeletal muscle myosin motors. Proc Natl Acad Sci U S A (2009) 1.18
Intrathecal polymer-based interleukin-10 gene delivery for neuropathic pain. Neuron Glia Biol (2006) 1.18
Statins block calcific nodule formation of valvular interstitial cells by inhibiting alpha-smooth muscle actin expression. Arterioscler Thromb Vasc Biol (2009) 1.16
Sex-based cardiac physiology. Annu Rev Physiol (2009) 1.13
Pregnancy as a cardiac stress model. Cardiovasc Res (2014) 1.11
MyoD, Myf5, and the calcineurin pathway activate the developmental myosin heavy chain genes. Dev Biol (2006) 1.09
The effects of biological sex and diet on the development of heart failure. Circulation (2007) 1.07
Intracellular calcium and myosin isoform transitions. Calcineurin and calcium-calmodulin kinase pathways regulate preferential activation of the IIa myosin heavy chain promoter. J Biol Chem (2002) 1.07
Identification of functional differences between recombinant human α and β cardiac myosin motors. Cell Mol Life Sci (2012) 1.06
Restoration of CREB function is linked to completion and stabilization of adaptive cardiac hypertrophy in response to exercise. Am J Physiol Heart Circ Physiol (2007) 1.06
Integrin-linked kinase production prevents anoikis in human mesenchymal stem cells. J Biomed Mater Res A (2007) 1.05
Skeletal myosin heavy chain function in cultured lung myofibroblasts. J Cell Biol (2003) 1.05
Erratum to: Identification of functional differences between recombinant human α and β cardiac myosin motors. Cell Mol Life Sci (2012) 1.01
Myocyte enhancer factor-2 and serum response factor binding elements regulate fast Myosin heavy chain transcription in vivo. J Biol Chem (2005) 1.01
Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T. Circulation (2004) 0.99
Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy. Circ Res (2003) 0.98
Mutations in the beta-myosin rod cause myosin storage myopathy via multiple mechanisms. Proc Natl Acad Sci U S A (2009) 0.98
Akt and MAPK signaling mediate pregnancy-induced cardiac adaptation. J Appl Physiol (1985) (2012) 0.97
Expression of cardiac troponin T with COOH-terminal truncation accelerates cross-bridge interaction kinetics in mouse myocardium. Am J Physiol Heart Circ Physiol (2004) 0.97
Whole transcriptome analysis of the fasting and fed Burmese python heart: insights into extreme physiological cardiac adaptation. Physiol Genomics (2010) 0.95
Mutations at the same amino acid in myosin that cause either skeletal or cardiac myopathy have distinct molecular phenotypes. J Mol Cell Cardiol (2009) 0.94
Activation of serum/glucocorticoid-induced kinase 1 (SGK1) is important to maintain skeletal muscle homeostasis and prevent atrophy. EMBO Mol Med (2012) 0.94
IIb or not IIb? Regulation of myosin heavy chain gene expression in mice and men. Skelet Muscle (2011) 0.93
Loss of desmin leads to impaired voluntary wheel running and treadmill exercise performance. J Appl Physiol (1985) (2003) 0.93
Yin Yang 1 represses alpha-myosin heavy chain gene expression in pathologic cardiac hypertrophy. Biochem Biophys Res Commun (2005) 0.92
A randomized library approach to identifying functional lox site domains for the Cre recombinase. Nucleic Acids Res (2007) 0.90
The role of Akt/GSK-3beta signaling in familial hypertrophic cardiomyopathy. J Mol Cell Cardiol (2009) 0.90
Increased thermoregulation in cold-exposed transgenic mice overexpressing lipoprotein lipase in skeletal muscle: an avian phenotype? J Lipid Res (2008) 0.90
Fighting fat with muscle: bulking up to slim down. Cell Metab (2008) 0.90
Effects of pathogenic proline mutations on myosin assembly. J Mol Biol (2011) 0.90
Metabolic crosstalk between the heart and liver impacts familial hypertrophic cardiomyopathy. EMBO Mol Med (2014) 0.90
Myosin heavy chain is not selectively decreased in murine cancer cachexia. Int J Cancer (2011) 0.89
Myh7b/miR-499 gene expression is transcriptionally regulated by MRFs and Eos. Nucleic Acids Res (2012) 0.89
Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males. Am J Physiol Heart Circ Physiol (2006) 0.89
Interferon-γ causes cardiac myocyte atrophy via selective degradation of myosin heavy chain in a model of chronic myocarditis. Am J Pathol (2012) 0.88
Calcineurin activity is required for cardiac remodelling in pregnancy. Cardiovasc Res (2013) 0.88
Intrathecal injection of naked plasmid DNA provides long-term expression of secreted proteins. Mol Ther (2008) 0.88
Alterations in mitochondrial function in a mouse model of hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol (2002) 0.88
Remodeling the cardiac transcriptional landscape with diet. Physiol Genomics (2011) 0.88
Characterization of cell subpopulations expressing progenitor cell markers in porcine cardiac valves. PLoS One (2013) 0.86
Diversity in transcriptional start site selection and alternative splicing affects the 5'-UTR of mouse striated muscle myosin transcripts. J Muscle Res Cell Motil (2006) 0.86
Serum deprivation improves seeding and repopulation of acellular matrices with valvular interstitial cells. J Biomed Mater Res A (2005) 0.85
Rational promoter selection for gene transfer into cardiac cells. J Mol Cell Cardiol (2003) 0.84
Cell type specific targeted intracellular delivery into muscle of a monoclonal antibody that binds myosin IIb. Mol Immunol (2003) 0.83
Estrogenic compounds are not always cardioprotective and can be lethal in males with genetic heart disease. Endocrinology (2012) 0.83
Distinct cardiac transcriptional profiles defining pregnancy and exercise. PLoS One (2012) 0.82
The superfast human extraocular myosin is kinetically distinct from the fast skeletal IIa, IIb, and IId isoforms. J Biol Chem (2013) 0.82
Acute effects of desmin mutations on cytoskeletal and cellular integrity in cardiac myocytes. Cell Motil Cytoskeleton (2003) 0.82
Interplay between exonic splicing enhancers, mRNA processing, and mRNA surveillance in the dystrophic Mdx mouse. PLoS One (2007) 0.81
Estimate of the abundance of cardiomyopathic mutations in the β-myosin gene. Int J Cardiol (2009) 0.81
A mutation in the beta-myosin rod associated with hypertrophic cardiomyopathy has an unexpected molecular phenotype. Biochem Biophys Res Commun (2009) 0.79
Regulation of physiological and metabolic function of muscle by female sex steroids. Med Sci Sports Exerc (2012) 0.79
Molecular and genetic approaches to studying exercise performance and adaptation. Exerc Sport Sci Rev (2002) 0.79
Immunogenicity of intrathecal plasmid gene delivery: cytokine release and effects on transgene expression. J Gene Med (2009) 0.78
Impaired skeletal muscle regeneration in the absence of fibrosis during hibernation in 13-lined ground squirrels. PLoS One (2012) 0.78
GFP fails to inhibit actin-myosin interactions in vitro. Nat Methods (2008) 0.77
Partnering up for cardiac hypertrophy. Circ Res (2006) 0.77
Myosin filament assembly requires a cluster of four positive residues located in the rod domain. FEBS Lett (2012) 0.76
Measuring microRNA reporter activity in skeletal muscle using hydrodynamic limb vein injection of plasmid DNA combined with in vivo imaging. Skelet Muscle (2013) 0.76
Estrogens mediate cardiac hypertrophy in a stimulus-dependent manner. Endocrinology (2012) 0.76
Frank Ruddle (1929-2013). Am J Hum Genet (2013) 0.75
Mechanisms of the pathogenesis of troponin T-based familial hypertrophic cardiomyopathy. Trends Cardiovasc Med (2003) 0.75
Rescuing cardiac malfunction: the roles of the chaperone-like small heat shock proteins. Circ Res (2008) 0.75
The role of MEKK1 in hypertrophic cardiomyopathy. Int Heart J (2010) 0.75
Task Force on Strategic Research Direction: Basic Science Subgroup key science topics report. Circulation (2002) 0.75
Suppressor tRNAs: protocols and applications for cardiac gene transfer. Methods Mol Biol (2003) 0.75
Direct gene transfer into mouse heart. Methods Enzymol (2002) 0.75